Ravi Muchhal
About Ravi Muchhal
Data last updated:
Ravi Muchhal is a Director at Shreepati Pharmaceuticals Pvt Ltd (since 1999) and Director at Shreepati Molecules Private Limited (since 2017). The companies operate in Pharma. The largest current company by reported revenue is Shreepati Pharmaceuticals Pvt Ltd at ₹27.91 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shreepati Pharmaceuticals Pvt Ltd U24232MP1995PTC009950 | Director | 16 Jun 1999 | 1995 | ₹27.91 Cr (FY 2025) | Active |
| Shreepati Molecules Private Limited U24290MP2017PTC043280 | Director | 11 May 2017 | 2017 | Active |
Board colleagues of Ravi Muchhal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhiraj Muchhal | 07134742 | Shreepati Pharmaceuticals Pvt Ltd | Director |
| Rajesh Muchhal | 00137701 | Shreepati Pharmaceuticals Pvt Ltd , Shreepati Molecules Private Limited | Director |
| Vedant Muchhal | 07134761 | Shreepati Pharmaceuticals Pvt Ltd | Director |
| Akshay Thakur | 01992911 | Shreepati Molecules Private Limited | Director |
| Kishor Rajaram Thakur | 00488423 | Shreepati Molecules Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Muchhal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Muchhal
Ravi Muchhal currently holds 2 directorships: Shreepati Pharmaceuticals Pvt Ltd (Director, since 16 Jun 1999, revenue ₹27.91 Cr (FY 2025)); Shreepati Molecules Private Limited (Director, since 11 May 2017).
Ravi Muchhal was first appointed on 16 Jun 1999 as Director at Shreepati Pharmaceuticals Pvt Ltd. The most recent appointment on record is 11 May 2017 at Shreepati Molecules Private Limited.
The current boards of Ravi Muchhal's companies include Dhiraj Muchhal (Shreepati Pharmaceuticals Pvt Ltd), Rajesh Muchhal (Shreepati Pharmaceuticals Pvt Ltd), Vedant Muchhal (Shreepati Pharmaceuticals Pvt Ltd), Akshay Thakur (Shreepati Molecules Private Limited), Kishor Rajaram Thakur (Shreepati Molecules Private Limited).